After a decade of research, medical researchers have revealed a new designer molecule that inhibits a well-validated cancer driver through the mechanism of amyloid formation. This work demonstrates that amyloid structures can be used to rationally develop a novel class of biotechnological molecules that are able to fight a wide array of diseases. Next steps to translate this groundbreaking technology into direct benefits for patients are already being explored.
After a decade of research, medical researchers have revealed a new designer molecule that inhibits a well-validated cancer driver through the mechanism of amyloid formation. This work demonstrates that amyloid structures can be used to rationally develop a novel class of biotechnological molecules that are able to fight a wide array of diseases. Next steps to translate this groundbreaking technology into direct benefits for patients are already being explored.
Share this Article
Recommended